Calidi Biotherapeutics Inc (CLDI) Stock Price, Quote & News

Company Profile

Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, develops allogeneic stem cell-based and enveloped virus platforms to potentiate and deliver oncolytic viruses in the United States. Its product pipeline comprises CLD-101, which is in Phase 1b/2 clinical trial for the treatment of high-grade glioma, as well as in Phase 1 dose-escalation clinical trial for recurrent high-grade glioma; CLD-201 product for solid tumors, such as breast cancer, head and neck squamous cell carcino...

Industry: Biotechnology

Sector: Healthcare

Phone: 858 794 9600

Fax: 858 794 9605

Website: www.calidibio.com

Address:

4475 Executive Drive, Suite 200, San Diego, United States

race2zero Apr. 25 at 5:30 PM

$CLDI in all honesty they are on the verge of a major cancer breakthrough or bankruptcy

1 · Reply

Daytrade_Samurai Apr. 25 at 5:12 PM

$CLDI I just put my kids college fund and the rest I had leftover on my house refi into this. So much potential. Warrant lockup is over and exercise price is .50 it will easily hit 1.25. I ain’t selling. Thank me later when we all get lambos.

0 · Reply

race2zero Apr. 25 at 4:10 PM

$CLDI

0 · Reply

Funktradee2 Apr. 25 at 3:44 PM

$CLDI What is this junk?

0 · Reply

race2zero Apr. 25 at 2:42 PM

$CLDI why would he do that one might ask…I have some theories….Eric Poma or Andrew Jackson, care to comment 🤣🤣🤦🏻‍♂️

1 · Reply

race2zero Apr. 25 at 2:41 PM

$CLDI for those keeping score at home, he bought 700k on March 8 and sold 780k on March 31

1 · Reply

race2zero Apr. 25 at 1:47 AM

$CLDI I wonder how he is doing

0 · Reply

race2zero Apr. 24 at 9:34 PM

$CLDI and it didn’t even move

0 · Reply

race2zero Apr. 24 at 9:33 PM

$CLDI doubling up on my short now, 100k buy and it didn’t even move the needle….this is the best insurance for a short, he will bail out way before this ever get momentum and a sell like that will stop any possible move up. Thank you for the insurance policy!

0 · Reply

race2zero Apr. 24 at 8:22 PM

$CLDI bruh, they just presented at the major cancer conference and it has done nothing but continue to tank. Milestones they left off of that chart are the reverse split from last summer, the two rounds of dilution, the upcoming reverse split, and the next round of dilution….they’ll never make it to end of 2026

0 · Reply

Calidi Biotherapeutics Presents New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026

Mar 27, 2026, 4:25 PM EDT - 4 weeks ago

Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Operational Highlights

Mar 12, 2026, 8:00 AM EDT - 6 weeks ago

Calidi Biotherapeutics Presents its Innovative and Scalable Manufacturing Process for CLD-401 at the 9th Annual Bioprocessing Summit; FDA Feedback Support Company's Approach to Manufacturing

Mar 9, 2026, 8:50 PM EDT - 6 weeks ago

Calidi Biotherapeutics Announces Closing of $6.0 Million Underwritten Public Offering and Full Exercise of Underwriters' Over-Allotment Option

Mar 6, 2026, 8:30 AM EST - 7 weeks ago

Calidi Biotherapeutics Announces Pricing of $5.2 Million Underwritten Public Offering

Mar 5, 2026, 5:57 PM EST - 7 weeks ago

Calidi Biotherapeutics Announces Proposed Public Offering

Feb 20, 2026, 8:00 AM EST - 2 months ago

Calidi Biotherapeutics Presents Data on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform at the 2026 AACR-IO Conference

Feb 12, 2026, 8:00 AM EST - 2 months ago

Calidi Biotherapeutics To Present on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform in a Late-Breaking Abstract at the 2026 AACR-IO Conference

Nov 17, 2025, 8:00 AM EST - 5 months ago

Calidi Biotherapeutics Announces Exclusive Live Investor Webinar and Q&A Session on November 19, 2025

Nov 13, 2025, 4:15 PM EST - 5 months ago

Calidi Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Operational Highlights

Aug 21, 2025, 6:33 PM EDT - 8 months ago

Calidi Biotherapeutics Announces Closing of $6.9 Million Underwritten Public Offering and Full Exercise of Underwriters' Over-Allotment Option

Aug 20, 2025, 9:15 AM EDT - 8 months ago

Calidi Biotherapeutics Announces Pricing of $6 Million Underwritten Public Offering

Aug 8, 2025, 4:15 PM EDT - 9 months ago

Calidi Biotherapeutics Reports Second Quarter 2025 Financial Results and Recent Operational Highlights

Jul 25, 2025, 4:45 PM EDT - 9 months ago

Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on August 5, 2025

Jul 22, 2025, 8:00 AM EDT - 9 months ago

Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on July 24

Jul 10, 2025, 8:30 AM EDT - 10 months ago

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Platform Designed to Transform Landscape of Cancer Treatment

Jul 9, 2025, 2:01 PM EDT - 10 months ago

Calidi Biotherapeutics Announces Exercise of Warrants for $4.6 Million of Gross Proceeds

Jul 8, 2025, 8:30 AM EDT - 10 months ago

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Developing Precision Genetic Medicine Platform for Cancer Treatment

Jun 27, 2025, 8:00 AM EDT - 10 months ago

Calidi Biotherapeutics Announces Shareholder Letter from CEO

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711

Apr 16, 2025, 9:30 AM EDT - 1 year ago

Global X Offers Precise U.S. Equity Exposure with Launch of Domestic Focused Funds

EGLE

Mar 31, 2025, 4:30 PM EDT - 1 year ago

Calidi Biotherapeutics Announces Closing of $3.9 Million Registered Direct Offering and Concurrent Private Placement

Mar 28, 2025, 9:00 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Pricing of $3.9 Million Registered Direct Offering and Concurrent Private Placement

Mar 10, 2025, 8:00 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Demonstrated Ability To Deliver Transient Gene Therapy (Payload) To Tumors Using Systemic Platform

Feb 28, 2025, 9:00 AM EST - 1 year ago

Calidi Biotherapeutics and OS Therapies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

OSTX

Feb 24, 2025, 8:00 AM EST - 1 year ago

Calidi Biotherapeutics Announces Commencement of Recruitment for Multiple Dose CLD-101 Trial in Patients with Newly Diagnosed High Grade Glioma at Northwestern University Hospital

Jan 29, 2025, 8:00 AM EST - 1 year ago

Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on February 5

Jan 28, 2025, 8:00 AM EST - 1 year ago

Calidi Biotherapeutics Announces Bolstered Cash Balance and Termination of its Standby Equity Purchase Agreement

Jan 10, 2025, 4:30 PM EST - 1 year ago

Calidi Biotherapeutics Announces Closing of $4.25 Million Public Offering of Common Stock

Jan 10, 2025, 8:30 AM EST - 1 year ago

Calidi Biotherapeutics Announces Pricing of $4.25 Million Public Offering of Common Stock

Nov 15, 2024, 4:05 PM EST - 1 year ago

Calidi Biotherapeutics Announces Closing of $7.5 Million Public Offering of Common Stock

Nov 14, 2024, 8:30 AM EST - 1 year ago

Calidi Biotherapeutics Announces Pricing of $7.5 Million Public Offering of Common Stock

Nov 12, 2024, 5:29 PM EST - 1 year ago

Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results

Oct 25, 2024, 9:00 AM EDT - 1 year ago

Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

NXL

Oct 24, 2024, 8:30 AM EDT - 1 year ago

Calidi Biotherapeutics to Present Data Supporting RTNova at Upcoming Scientific Conferences

Oct 23, 2024, 8:31 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement

Oct 18, 2024, 11:00 PM EDT - 1 year ago

NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS)

Oct 18, 2024, 8:45 AM EDT - 1 year ago

Calidi Biotherapeutics and Gorilla Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

GRRR

Aug 13, 2024, 5:37 PM EDT - 1 year ago

Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial Results

Aug 2, 2024, 9:00 AM EDT - 1 year ago

GreenPower Motor and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Jul 29, 2024, 9:00 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Launch of Nova Cell Subsidiary and $3 Million Aggregate Investment from Dr. Ronald Rigor

Jul 18, 2024, 8:00 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform

Jul 16, 2024, 8:00 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Appointment of Dr. Mark Gilbert to Medical Advisory Board

Jul 5, 2024, 4:15 PM EDT - 1 year ago

Calidi to Effect Reverse Stock Split

Jun 27, 2024, 7:00 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Appointment of Cancer Immunotherapy Pioneer Dr. George Peoples to Board of Directors

Jun 11, 2024, 4:05 PM EDT - 2 years ago

Calidi Biotherapeutics to Host Exclusive Live Investor Webinar and Q&A Session on June 13

Jun 10, 2024, 7:00 AM EDT - 2 years ago

Calidi Biotherapeutics Collaborates with SIGA Technologies to Advance Calidi's Revolutionary RTNova Virotherapy for Lung Cancer and Metastatic Solid Tumors

race2zero Apr. 25 at 5:30 PM

$CLDI in all honesty they are on the verge of a major cancer breakthrough or bankruptcy

1 · Reply

Daytrade_Samurai Apr. 25 at 5:12 PM

0 · Reply

race2zero Apr. 25 at 4:10 PM

$CLDI

0 · Reply

Funktradee2 Apr. 25 at 3:44 PM

$CLDI What is this junk?

0 · Reply

race2zero Apr. 25 at 2:42 PM

$CLDI why would he do that one might ask…I have some theories….Eric Poma or Andrew Jackson, care to comment 🤣🤣🤦🏻‍♂️

1 · Reply

race2zero Apr. 25 at 2:41 PM

$CLDI for those keeping score at home, he bought 700k on March 8 and sold 780k on March 31

1 · Reply

race2zero Apr. 25 at 1:47 AM

$CLDI I wonder how he is doing

0 · Reply

race2zero Apr. 24 at 9:34 PM

$CLDI and it didn’t even move

0 · Reply

race2zero Apr. 24 at 9:33 PM

0 · Reply

race2zero Apr. 24 at 8:22 PM

0 · Reply

BiotechSheff Apr. 24 at 7:58 PM

$CLDI - Upcoming catalysts here! May 14th is ASGCT meeting. New data presentation there.

0 · Reply

race2zero Apr. 24 at 7:54 PM

$CLDI hope y’all were able to unload on that major run to .2278

0 · Reply

StockAuthority Apr. 24 at 7:43 PM

$CLDI doubled my shares just now

1 · Reply

seanpfett Apr. 24 at 7:43 PM

$CLDI huge buy!! $GMEX great run today 💵

0 · Reply

seanpfett Apr. 24 at 7:42 PM

$CLDI looks like a huge buy went through 👀 $OBAI nice reversal 👏

0 · Reply

race2zero Apr. 24 at 7:35 PM

$CLDI those bookend blocks just keeping walking down lower, why would anyone buy this scam?

0 · Reply

race2zero Apr. 24 at 7:01 PM

$CLDI I love that every person with hope for this POS has me blocked🤣🤣rather than reading the truth, it’s easier to just keep losing money

0 · Reply

seanpfett Apr. 24 at 6:44 PM

$CLDI clidoris ready to rip

0 · Reply

race2zero Apr. 24 at 6:10 PM

$CLDI I’m counting on you bulls to keep this above .20 until the reverse split announcement that could very well come AH today. It wants to go below .20 bad, but I’m loading up more on Monday for the 50% drop on the news

0 · Reply

race2zero Apr. 24 at 6:00 PM

$CLDI it’s been dipping since it got listed..🤣🤣🤣 down 99.98%

0 · Reply

mr_bowjangles Apr. 24 at 5:51 PM

$CLDI cmon clidoris

0 · Reply

Funktrade Apr. 24 at 5:32 PM

$CLDI seriously,what the fuck is going on here . Down 80% in 3 months with POSITIVE CANCER NEWS ??? FUCKING CRIMINAL 😡😡😡😡

0 · Reply

Market Cap	2.40M
Revenue (ttm)	0.00
Net Income (ttm)	-19.91M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.16

Volume	2,927,200
Avg Vol	1,072,062
Day's Range	N/A - N/A
Shares Out	10.90M
Stochastic %K	17%
Beta	1.42
Analysts	Strong Buy
Price Target	$10.00